Ascofuranone: a possible therapeutic tool for autosomal dominant polycystic kidney disease?
Vincenzo
V
Cardinale
Domenico
D
Alvaro
D002453:Cell Cycle / Q000187:drug effects / Q000235:genetics; D049109:Cell Proliferation / Q000187:drug effects; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000235:genetics / Q000378:metabolism; D054697:Cytostatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D009154:Mutation / Q000502:physiology; D016891:Polycystic Kidney, Autosomal Dominant / Q000188:drug therapy*; D012717:Sesquiterpenes / Q000494:pharmacology* / Q000627:therapeutic use; D050396:TRPP Cation Channels / Q000235:genetics
D050759:Cyclin-Dependent Kinase Inhibitor p21; D054697:Cytostatic Agents; D012717:Sesquiterpenes; D050396:TRPP Cation Channels; C006640:ascofuranone